Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Severe sepsis, coagulation, and fibrinolysis: dead end or one way?

Fourrier F.

Crit Care Med. 2012 Sep;40(9):2704-8. doi: 10.1097/CCM.0b013e318258ff30. Review.

PMID:
22732284
2.

Coagulation and sepsis: a winding road ahead.

Levi M.

Crit Care Med. 2012 Sep;40(9):2733-4. doi: 10.1097/CCM.0b013e31825ce4e8. No abstract available.

PMID:
22903108
3.

The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis.

Zarychanski R, Abou-Setta AM, Kanji S, Turgeon AF, Kumar A, Houston DS, Rimmer E, Houston BL, McIntyre L, Fox-Robichaud AE, Hébert P, Cook DJ, Fergusson DA; Canadian Critical Care Trials Group..

Crit Care Med. 2015 Mar;43(3):511-8. doi: 10.1097/CCM.0000000000000763. Review.

PMID:
25493972
4.

Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock.

Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, Strauss R, Meier-Hellmann A, Insel R, Radke J, Schüttler J, Gärtner R.

Crit Care Med. 2007 Jan;35(1):118-26.

PMID:
17095947
5.

Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: a double-blind randomized placebo controlled trial.

Boerma EC, Koopmans M, Konijn A, Kaiferova K, Bakker AJ, van Roon EN, Buter H, Bruins N, Egbers PH, Gerritsen RT, Koetsier PM, Kingma WP, Kuiper MA, Ince C.

Crit Care Med. 2010 Jan;38(1):93-100. doi: 10.1097/CCM.0b013e3181b02fc1.

PMID:
19730258
6.

Protein C concentrate to restore physiological values in adult septic patients.

Baratto F, Michielan F, Meroni M, Dal Palù A, Boscolo A, Ori C.

Intensive Care Med. 2008 Sep;34(9):1707-12. doi: 10.1007/s00134-008-1140-6.

PMID:
18458873
7.

Septic shock: a multidisciplinary response team and weekly feedback to clinicians improve the process of care and mortality.

Schramm GE, Kashyap R, Mullon JJ, Gajic O, Afessa B.

Crit Care Med. 2011 Feb;39(2):252-8. doi: 10.1097/CCM.0b013e3181ffde08.

PMID:
21057312
8.

Practice and perception--a nationwide survey of therapy habits in sepsis.

Brunkhorst FM, Engel C, Ragaller M, Welte T, Rossaint R, Gerlach H, Mayer K, John S, Stuber F, Weiler N, Oppert M, Moerer O, Bogatsch H, Reinhart K, Loeffler M, Hartog C; German Sepsis Competence Network (SepNet)..

Crit Care Med. 2008 Oct;36(10):2719-25. doi: 10.1097/CCM.0b013e318186b6f3.

PMID:
18766100
9.

[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] .

Baudo F, de Cataldo F.

Minerva Anestesiol. 2000 Nov;66(11 Suppl 1):3-23. Review. Italian.

PMID:
11213542
10.

Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock.

Mikkelsen ME, Miltiades AN, Gaieski DF, Goyal M, Fuchs BD, Shah CV, Bellamy SL, Christie JD.

Crit Care Med. 2009 May;37(5):1670-7. doi: 10.1097/CCM.0b013e31819fcf68.

PMID:
19325467
11.
12.

Treatment of sepsis with activated protein C.

Hinds CJ.

BMJ. 2001 Oct 20;323(7318):881-2. No abstract available.

13.

Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis.

Tidswell M, Tillis W, Larosa SP, Lynn M, Wittek AE, Kao R, Wheeler J, Gogate J, Opal SM; Eritoran Sepsis Study Group..

Crit Care Med. 2010 Jan;38(1):72-83. doi: 10.1097/CCM.0b013e3181b07b78. Erratum in: Crit Care Med. 2010 Sep;38(9):1925-6. Multiple investigator names added..

PMID:
19661804
14.

Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation.

Levi M, de Jonge E, van der Poll T.

Crit Care Med. 2001 Jul;29(7 Suppl):S90-4. Review.

PMID:
11445740
15.
16.

[Clinical trials for severe sepsis/DIC].

Kushimoto S.

Rinsho Byori. 2011 Feb;Suppl 147:85-94. Japanese. No abstract available.

PMID:
21761754
17.

Clinical impact of novel anticoagulation strategies in sepsis.

Opal SM.

Curr Opin Crit Care. 2001 Oct;7(5):347-53. Review.

PMID:
11805532
18.

Use of protein C concentrate in pediatric patients with sepsis.

Silvani P, Camporesi A, Licari E, Wolfler A.

Minerva Anestesiol. 2005 Jun;71(6):373-8.

19.

A role for the micro-organism in the outcome from infection? A principle challenged.

Cohen J.

Crit Care Med. 2011 Aug;39(8):2001-2. doi: 10.1097/CCM.0b013e31821e85b5. No abstract available.

PMID:
21768806
20.
Items per page

Supplemental Content

Support Center